Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effects of the DPP-4 or SGLT2 Inhibitors on the Metabolic Cardiovascular Systems in Patients With Type 2 Diabetes Mellitus.

NCT02528019 is registered in ClinicalTrials.gov with Kurume University as lead sponsor.

NCT NCT02528019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02528019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effects of the DPP-4 or SGLT2 Inhibitors on the Metabolic Cardiovascular Systems in Patients With Type 2 Diabetes Mellitus.
Lead sponsor
Kurume University
Phase
Phase 4
Overall status
Unknown status
Start date
August 31, 2015
Completion date
August 31, 2018
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

effects of the dpp-4 inhibitors or sglt2 inhibitors on the protective actions for diabetic complications